Clinical Trial: Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Target-controlled Infusion of Remifentanil for Laryngeal Mask Airway Insertion During Sevoflurane Induction in Adults
Brief Summary: The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Detailed Summary: For practical purposes, opioids with the ability to suppress upper airway reflexes have been used to facilitate insertion of the LMA during anaesthesia induction. To date, however, there have been no published reports addressing the use of remifentanil to facilitate LMA insertion during sevoflurane inhalation induction in adults. Therefore, the purpose of this study was to determine the most suitable effect-site concentration of remifentanil target-controlled infusion (TCI) for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Sponsor: Gachon University Gil Medical Center
Current Primary Outcome: LMA Insertion Condition [ Time Frame: at that time on LMA insertion only ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Frequency of Apnea [ Time Frame: baseline, 30sec after drug injection ]
Original Secondary Outcome: Same as current
Information By: Gachon University Gil Medical Center
Dates:
Date Received: October 19, 2011
Date Started: April 2011
Date Completion:
Last Updated: April 17, 2014
Last Verified: April 2014